ArticleSubstance abuse treatment, prevention, and policy2020
A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use.
Article in Substance abuse treatment, prevention, and policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05594121 (A Pragmatic, Multi-centre, Open-label, Randomized, 12-month, Parallel Group, Superiority Study to Compare the Effectiveness of Subcutaneous Buprenorphine Depot), which is not on this map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Pragmatic, Multi-centre, Open-label, Randomized, 12-month, Parallel Group, Superiority Study to Compare the Effectiveness of Subcutaneous Buprenorphine Depot (Sublocade®) vs Daily Sublingual Buprenorphine With Naloxone (Suboxone®) for the Treatment of Opioid Use Disorder
Who cites it
27 citing papers in PubMed, 54 citations in OpenAlex.
- Facilitating rapid access to addiction treatment: a randomized controlled trial.Addiction science & clinical practice · 2021Trial
- Equity-Related Determinants of Frequent Emergency Department Visits for Substance Use Disorders: A Population-Based Study in Ontario, Canada.The International journal of social psychiatry · 2026Article
- Models of care for the management of alcohol use disorder in general hospital settings and transition to the community: a scoping review.Alcohol and alcoholism (Oxford, Oxfordshire) · 2026Article
- "With this you're not chained down to something": contrasting experiences of opioid agonist treatment and safer supply program participation among people receiving prescribed safer supply.Harm reduction journal · 2026Article
- Facilitator perspectives on in-person versus videoconference delivery of a remedial intervention for impaired drivers: a qualitative study.Addiction science & clinical practice · 2025Article
- Who Should Respond to Substance-Exposed Infants? Reflections on U.S. Policies Limiting the Role of Child Protective Services.Child protection and practice · 2025Article
- Patient Perspectives on a Rapid Access, Walk-in, Medication for Addiction Treatment Clinic.Substance abuse and rehabilitation · 2025Article
- Reframing conceptualizations of primary care involvement in opioid use disorder treatment.BMC primary care · 2024Article
- Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2024Article
- What features of drug treatment programs help, or not, with access? a qualitative study of the perspectives of family members and community-based organization staff in Atlantic Canada.Substance abuse treatment, prevention, and policy · 2024Article
- Harm reduction in undergraduate and graduate medical education: a systematic scoping review.BMC medical education · 2023Article
- Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use.JAMA network open · 2023Article
- Building an inpatient addiction medicine consult service in Sudbury, Canada: preliminary data and lessons learned in the era of COVID-19.Substance abuse treatment, prevention, and policy · 2023Observational
- Changes in health service use due to alcohol during the COVID-19 pandemic among individuals with and individuals without pre-existing alcohol-related medical diagnoses.Canadian journal of public health = Revue canadienne de sante publique · 2023Article
- A Rapid Review of "Low-Threshold" Psychiatric Medication Prescribing: Considerations for Street Medicine and Beyond.Psychiatric services (Washington, D.C.) · 2023Review
- A Mobile Health App (ChillTime) Promoting Emotion Regulation in Dual Disorders: Acceptability and Feasibility Pilot Study.JMIR formative research · 2023Article
- Exploring arts-based interventions for youth substance use prevention: a scoping review of literature.BMC public health · 2022Article
- Mortality Risk Following Nonfatal Injuries With Alcohol Use Disorder Involvement: A One-Year Follow-Up of Emergency Department Patients Using Linked Administrative Data.Journal of studies on alcohol and drugs · 2022Article
- Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study.Journal of substance abuse treatment · 2022Article
- A novel home- and community-based mobile outreach detoxification service for individuals identifying problematic substance use: implementation and program evaluation.Canadian journal of public health = Revue canadienne de sante publique · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubstance use is prevalent in Canada, yet treatment is inaccessible. The Rapid Access to Addiction Medicine (RAAM) clinic opened at the University Health Network (UHN) in January 2018 as part of a larger network of addictions clinics in Toronto, Ontario, to enable timely, low barrier access to medical treatment for substance use disorder (SUD). Patients attend on a walk-in basis without requiring an appointment or referral. We describe the RAAM clinic model, including referral patterns, patient demographics and substance use patterns. Secondary outcomes include retention in treatment and changes in both self-reported and objective substance use.
methodsThe Electronic Medical Record at the clinic was reviewed for the first 26 weeks of the clinic's operation. We identified SUD diagnoses, referral source, medications prescribed, retention in care and self-reported substance use.
resultsThe clinic saw 64 unique patients: 66% had alcohol use disorder (AUD), 39% had opiate use disorder (OUD) and 20% had stimulant use disorder. Fifty-five percent of patients were referred from primary care providers, 30% from the emergency department and 11% from withdrawal management services. Forty-two percent remained on-going patients, 23% were discharged to other care and 34% were lost to follow-up. Gabapentin (39%), naltrexone (39%), and acamprosate (15%) were most frequently prescribed for AUD. Patients with AUD reported a significant decrease in alcohol consumption at their most recent visit. Most patients (65%) with OUD were prescribed buprenorphine, and most patients with OUD (65%) had a negative urine screen at their most recent visit.
conclusionThe RAAM model provides low-barrier, accessible outpatient care for patients with substance use disorder and facilitates the prescription of evidence-based pharmacotherapy for AUD and OUD. Patients referred by their primary care physician and the emergency department demonstrated a reduction in median alcohol consumption and high rates of opioid abstinence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.